Alex Wilson
Fortuna: - $ al 30/06/2026
Fortuna: - $ al 30/06/2026
Alex Wilson currently works at AEON Biopharma, Inc. as Secretary, Chief Legal Officer & Executive VP since 2021.
Formerly, Mr. Wilson worked at Glaukos Corp.
as Associate General Counsel & Business Development and at O'Melveny & Myers LLP as Head-Counsel.
Education includes undergraduate studies at Brigham Young University and graduate studies at UCLA School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AEON BIOPHARMA, INC. | Consejero General | 01/08/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| GLAUKOS CORPORATION | Corporate Officer/Principal | 01/08/2021 |
O'Melveny & Myers LLP
O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 5 |
|---|---|
Glaukos Corp.
Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
O'Melveny & Myers LLP
O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA School of Law
UCLA School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AEON Biopharma, Inc.
AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.